Patent details
EP2279254 Title: NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- EP2279254
- WO Application Number:
- CA2009000496
- Type:
- European Patent Granted for NL
- Status:
- Patent in Force
- Publication Title:
- Title When Made Available For Viewing:
- Reason Lapsed:
- Application number:
- EP09731866.1
- WO Publication Number:
- WO2009127060
- EPO Publication Language:
- English
- SPC Number:
- First Applicant Residence Country:
- Canada (CA)
- Publications:
Dates
- Filing date:
- 15/04/2009
- Grant date:
- 05/07/2017
- EP Publication Date:
- 02/02/2011
- WO Publication Date:
- 22/10/2009
- Claims Translations Received Date:
- Claims Translation B1 Received Date:
- 02/10/2017
- Claims Translation B2 Received Date:
- Claims Translation B3 Received Date:
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Published:
- Due To Cession Date:
- Registration date:
- 05/07/2017
- EP B1 Publication Date:
- 05/07/2017
- EP B2 Publication Date:
- EP B3 Publication Date:
- Description Translation B1 Received Date:
- Description Translation B2 Received Date:
- Description Translation B3 Received Date:
- Expiration date:
- 14/04/2029
- Lapsed By Expiration Date:
- Patent Validated Date:
- 11/10/2017
- Revocation Date:
- Invalidity Date:
- Response To Novelty Search Report Received:
- Patent Granting Request:
- Lapsed date:
Applicant/holder
- From:
- 17/12/2020
- Name:
- ARBUTUS BIOPHARMA CORPORATION
- Address:
- 25th Floor, 700 West Georgia Street, V7Y 1B3 BC, Vancouver, Canada (CA)
Historical Applicant/holder
- From:
- 05/07/2017
- To:
- 17/12/2020
- Name:
- Protiva Biotherapeutics Inc.
- Address:
- 100-8900 Glenlyon Parkway, BURNABY, BRITISH COLUMBIA V5J 5J8, Canada (CA)
Domicile Holder
- Name:
- ir. M.F.J.M. Ketelaars c.s.
- From:
- 02/10/2017
- Address:
- NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
- To:
Inventor
1
- Name:
- MACLACHLAN, Ian
- Address:
- Mission, B.C. V4S 1E5, Canada (CA)
2
- Name:
- YAWORSKI, Edward
- Address:
- Maple Ridge, B.C. V2X 9Z7, Canada (CA)
3
- Name:
- LAM, Kieu
- Address:
- Surrey, B.C. V4N 5M7, Canada (CA)
4
- Name:
- JEFFS, Lloyd B.
- Address:
- Delta, B.C. V4K 3B4, Canada (CA)
5
- Name:
- PALMER, Lorne R.
- Address:
- Vancouver, B.C. V5S 2P2, Canada (CA)
Priority
- Priority Patent Number:
- 45228 P
- Priority Date:
- 15/04/2008
- Priority Country:
- United States of America (US)
Classification
- IPC or IDT classification:
- A61K 9/127; A61K 31/712; A61K 31/713; A61P 35/00; C12N 15/88; C12N 15/113;
Publication
Bulletin
1
- Bulletin Heading:
- CO
- Journal edition number:
- 52/20
- Publication date:
- 23/12/2020
- Description:
- Changes in the Netherlands Patent Register
2
- Bulletin Heading:
- EP3
- Journal edition number:
- 41/17
- Publication date:
- 11/10/2017
- Description:
- European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
3
- Bulletin Heading:
- EP2
- Journal edition number:
- 27/17
- Publication date:
- 05/07/2017
- Description:
- European patents granted for the Netherlands
European Patent Bulletin
- Issue number:
- 201727
- Publication date:
- 05/07/2017
- Description:
- Grant (B1)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Merge
- Deed Number:
- RC202002512A
- Date Registered:
- 17/12/2020
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. M.F.J.M. Ketelaars c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- ARBUTUS BIOPHARMA CORPORATION
- Address:
- 25th Floor, 700 West Georgia Street, V7Y 1B3 BC, Vancouver, Canada (CA)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- 30/04/2025
- Annual Fee Number:
- 17
- Annual Fee Amount:
- 1100 Euro
- Last Annual Payment Date:
- 23/04/2024
- Last Annual Fee Paid Number:
- 16
- Last Annual Fee Paid Amount:
- 1000 Euro
- Payer:
- Murgitroyd & Company
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 11/10/2017 | Outgoing Correspondence | Letter no formal defects | 1 | /4/6/4/1/7/0800171464/docs/ep09731866.1_2_166947l271.pdf | ||
| 02/10/2017 | Incoming Correspondence Electronic | Accompanying letter incoming document | 2 | /4/6/4/1/7/0800171464/docs/ep09731866.1_0_incomingcorrespondenceelectronic20171002110824751.pdf | ||
| 02/10/2017 | Claims | First filed claims | 3 | /4/6/4/1/7/0800171464/docs/ep09731866.1_1_claims20171002110822551.pdf |